Moatly / Stocks / CRL

Charles River Laboratories (CRL) — what is it worth?

$345.80 · $16.6B market cap · Medical - Diagnostics & Research
Scored from reported financial statements. Data as of 2026-11-11.
Moat
45
Durability of advantage
Management
32
Returns and capital use
Margin of safety
1
Price against value
Buy price
$103.27
Consensus of three methods
Intrinsic value
$5.56
What the business is worth
Margin of safety price
$2.78
Intrinsic value less 50%
10-CAP price
$96.01
Ten times owner earnings
Payback time price
$103.27
Eight years of free cash flow
Moatly AI Insight

Charles River Laboratories scores 32 for management and 45 for moat. The management score rests on a return on invested capital of 8.4% and a gross margin of 30.5% — figures that describe capital earning less than it costs to employ. Debt sits at 0.97x equity. A moderate moat alongside weak management is a combination worth understanding before the price matters at all.

The price anchors are built on deliberately conservative assumptions. Growth is modelled at 6.5% a year, below the 7.0% actually measured over the last decade — the model caps growth rather than extrapolating a good run forwards. The exit multiple assumed is 13.1x. That produces an intrinsic value of $5.56, a 10-CAP price of $96.01 and a payback time price of $103.27, with the value zone set at the highest of the three, $103.27. Today's price of $345.80 is 235% above it.

The price is above the value zone and the business scores 45 for moat and 32 for management. Neither test argues for paying up here.

Key figures

Price$345.80
Market cap$16.6B
P/E ratio380.0x
Return on invested capital8.4%
Gross margin30.5%
Debt to equity0.97x
Free cash flow yield5.1%
Growth rate used6.5%
Growth rate measured7.0%
Exit multiple assumed13.1x

How it compares

CompanyMoatBuy price
Eurofins Scientific (ERFSF)47$113.56
Icon Plc (ICLR)52$277.12
Medpace Holdings Inc (MEDP)86$380.71
Quest Diagnostics (DGX)62$138.20

Be in the know

Subscribe to our Substack for deeper insights on value plays.

Subscribe free

Run your own assumptions

Every number above is built on assumptions that can be changed. In Moatly you can move the growth rate, the exit multiple and the margin of safety and watch every figure recalculate, so you are testing your own view of Charles River Laboratories rather than accepting ours.

Download on the App StoreGet it on Google Play

Not investment advice. Estimates only, built on stated assumptions that could be wrong. Figures are drawn from reported financial statements and were current as of the date shown. Do your own research.